By Colin Kellaher Aclaris Therapeutics shares crumbled nearly 90% and hit an all-time low after the clinical-stage biopharmaceutical company threw…
Stay informed with free updatesSimply sign up to the US interest rates myFT Digest -- delivered directly to your inbox.US…
By Helena Smolak Eramet is set to invest around 1.9 billion euros ($2.03 billion) from 2024 to 2026 to boost…
Stay informed with free updatesSimply sign up to the Climate change myFT Digest -- delivered directly to your inbox.Global greenhouse…
By Adriano Marchese Toronto stocks were trading higher in midday trading Monday while investors await Tuesday's U.S. inflation report. Sector…
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Wall Street…
By Michael Susin Surface Transforms said it intends to raise around 8 million pounds ($9.8 million) through a placing, and…
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Al-Shifa hospital,…
Sign in to your account
